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Abstract
Magnetic nanoparticles (NPs) of superparamagnetic iron oxide (SPIO) have been explored for different kinds of
applications in biomedicine, mechanics, and information. Here, we explored the synthetic SPIO NPs as an adjuvant
on antigen cross-presentation ability by enhancing the intracellular delivery of antigens into antigen presenting
cells (APCs). Particles with different chemical modifications and surface charges were used to study the mechanism
of action of antigen delivery. Specifically, two types of magnetic NPs, γFe2O3/APTS (3-aminopropyltrimethoxysilane)
NPs and γFe2O3/DMSA (meso-2, 3-Dimercaptosuccinic acid) NPs, with the same crystal structure, magnetic
properties, and size distribution were prepared. Then, the promotion of T-cell activation via dendritic cells (DCs) was
compared among different charged antigen coated NPs. Moreover, the activation of the autophagy, cytosolic
delivery of the antigens, and antigen degradation mediated by the proteasome and lysosome were measured. Our
results indicated that positive charged γFe2O3/APTS NPs, but not negative charged γFe2O3/DMSA NPs, enhanced
the cross-presentation ability of DCs. Increased cross-presentation ability induced by γFe2O3/APTS NPs was
associated with increased cytosolic antigen delivery. On the contrary, γFe2O3/DMSA NPs was associated with rapid
autophagy. Overall, our results suggest that antigen delivered in cytoplasm induced by positive charged particles is
beneficial for antigen cross-presentation and T-cell activation. NPs modified with different chemistries exhibit
diverse biological properties and differ greatly in their adjuvant potentials. Thus, it should be carefully considered
many different effects of NPs to design effective and safe adjuvants.
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Background
It is taken for granted that adjuvants are key compo-
nents of vaccines and play an important role in a strong
immune response. New generation of adjuvants, includ-
ing toll like receptors (TLRs) activating agonists [1, 2],
pH-responsive polymeric NPs [3], gene-silencing com-
plexes [4, 5] and so on, is being developed to induce a
more effective cell-mediated immune response against
tumor, intracellular bacteria or viruses. As an important
approach, biomedical applications of nanomaterials are
usually related to the immune system and deeply involved
in health and disease. Therefore, the interactions of
adjuvant NPs with the immune system and its potential
effects and implications are key questions that should be
answered to take full advantage of such approaches.
Due to the multifunctional properties of SPIO NPs,
such as small particle size, superparamagnetism, and
biocompatibility, there are many different kinds of these
particle applications in biomedicine, mechanics, and
information. In biomedicine, many studies demonstrate
SPIO NP applications in diagnosis and treatment, such
as a contrast enhancement agent for magnetic resonance
imaging, drug carriers for a drug delivery system, gener-
ator of heat for tumor hyperthermia and detoxification
of biological fluids [6–8]. Recent reports show that NPs,
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such as Al2O3, TiO2, ZnO, or SiO2 NPs, can be used as
an antigen delivery carrier to absorb and bring more an-
tigens into APCs, which are slowly released into the
APCs, resulting in an enhanced the immune response
[9–11]. As the mental adjuvant NPs, γFe2O3 NPs with
positive charge characteristic could be absorbed by
protein with negative charge, which may has the simi-
lar characteristic to promote the immune response
accompany with their functions of cells labeling and
tracking [12, 13].
In the development of adaptive immunity to tumours
and most infectious pathogens, professional APCs, such
as DCs, are capable of presenting exogenous antigens to
CD8 positive cytotoxic T lymphocytes in a pivotal
process, which is known as antigen cross-presentation.
Cross-presentation is a sequential, multi-step process
that involves antigen internalization, protein degrad-
ation, and loading of antigen-derived peptides into major
histocompatibility complex class I (MHC-I) molecules of
APCs. The classical and effective pathway of antigen
cross-presentation has been studied in detail [14]. Cyto-
solic and nuclear antigens are degraded into peptides by
the proteasome and transported from the cytosol into
the endoplasmic reticulum (ER) by the protein trans-
porter TAP. These peptides are then loaded onto newly
synthesized MHC-I, and these complexes released from
the ER are transported to the cell surface via the Golgi
[14]. Up to date, some antigen-nanoparticle complexes
could enhance antigen cross-priming of cytotoxic T lym-
phocytes, but the mechanisms are still poorly understood.
In this study, we sought to investigate that synthetic
γFe2O3 NPs modified with opposite charged polymers
have different functions as an adjuvant property for their
ability to promote cell-mediated immunity. Furthermore,
we presented a novel direction of antigen carried by NPs
modified with different chemistries exhibiting diverse
delivery passway in their adjuvant potentials.
Methods
Preparation of the SPIO
γFe2O3 NPs were prepared according to the method we
described previously [12]. Briefly, a solution of FeCl3 and
FeSO4 (molar ratio 2:1) was prepared under N2 protec-
tion and stirred vigorously at room temperature for
30 min. The resulting Fe3O4 NPs were obtained and
washed immediately with distilled water five times by
magnetic separation. The final precipitates were dis-
persed in distilled water at a concentration of 3 mg/ml
and a pH of 3.0. Finally, the precipitates were oxidized
into brown γFe2O3 NPs by aeration at 95 °C, γFe2O3
NPs were then coated with DMSA and APTS according
to the process described in literature [15]. Briefly, DMSA
aqueous solution was added to 100 ml of γFe2O3 NPs
solution (molar ratio of DMSA and [Fe] was 1:40). The
reaction was carried out for 4 h with continuous stirring.
γFe2O3 NPs (2 mg/ml) was stirred at a rate of 500 rpm
at 50 °C. APTS (APTS and [Fe] was 0.2:1) was added
and stirred for 5 h. The precipitate was separated with a
permanent magnet, washed with deionized water and, at
the same time, placed in an ultra sonicator. Finally, the
NPs samples were dried into powder at room temperature
under vacuum.
Cell Lines
The Mutu DC cell line, named for murine tumor and
kindly provided by Prof. Hans Acha-Orbea (University
of Lausanne, Switzerland), was originated from spleen
tumors in CD11c:SV40LgT-transgenic C57BL/6 mice
[16]. B3Z cell line, a CD8
+ T cell hybridoma expressing
LacZ gene when its T cell receptor engages an OVA258–
265 epitope in the context of H-2K
b MHC class I mol-
ecule, was a gift of Prof. Nilabh Shastri (University of
California, Berkeley, CA) [17].
Electron Microscopy Imaging and Surface Charges of
Particles
Mutu DCs (2 × 106) were incubated with the particles,
either γFe2O3/APTS or γFe2O3/DMSA (50 μg/mL) for
6 h, which were cocultured with OVA protein (10 μg/ml,
Sigma-Aldrich) for 1 h before cocultured with cells.
After being fixed, ultra-thin sections (90 nm) were cut
and stained with 1% osmium tetroxide and 0.8% potas-
sium ferrocyanide in 100 mM sodium cacodylate buffer
for 2 h. After being rinsed, stained, and dehydrated, sam-
ples were then infiltrated with a 1:1 mix of acetone and
Epon 812 (EMS cat#14120) overnight with rotation.
After this incubation step, the 1:1 mix was replaced with
Epon 812 and allotted time to polymerize overnight at
60 °C. Thin sections obtained from the block face were
imaged at 80 kV on a FEI-Tecnai 12 system interfaced to
a digital camera and analyzed with the associated soft-
ware (Advanced Microscopy Techniques, Danvers, MA).
The surface charges of NPs with or without OVA
protein were measured by a zeta potential assay [15].
The particles of γFe2O3/APTS, γFe2O3/DMSA, OVA-
γFe2O3/APTS, and OVA-γFe2O3/DMSA were prepared
with different pH values from 3 to 8 and the concentra-
tions of NPs and OVA were adjusted to 25 and 2.5 μg/
ml, respectively. The zeta potentials of the samples were
measured using a zetasizer Nano ZS90 potential analyzer
(Malvern, UK).
In Vitro Antigen Cross-Presentation Assay
Mutu DCs and transporter associated with antigen pro-
cessing 1 (TAP1) knockout DCs (2 × 104) were pulsed
with γFe2O3 NPs coated with different polymers with or
without proteasomal inhibitor, Bortezomib/Velcade
(200nM, Millennium), and lysosomal inhibitor, NH4Cl
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(20 μM, Sigma-Aldrich), which incubated with OVA
protein (10 μg/ml, Sigma-Aldrich) for 1 h at room
temperature. After 6 h, DCs were cocultured with B3Z
(2 × 105) overnight. The B3Z cells response was mea-
sured as β-galactosidase activity induced upon ligand
recognition. The β-galactosidase activity was measured
by the sample’s absorbance at 595 nm, the absorbance of
the cleavage product of Chlorophenol Red-β-D-Galacto-
pyranoside (CPRG, Sigma-Aldrich). The assay of antigen
cross-presentation was called CPRG in this study.
Western Blot and Bicinchoninic Acid (BCA) Analysis
In order to detect OVA expression in DCs, cells (5 ×
106) were pulsed with γFe2O3/APTS, γFe2O3/DMSA
(100 μg/ml) cocultured with OVA (10 μg/ml) for 6 hours,
and then cytosol collected after treated by Perfringolysin
O (PFO, 100 ng/ml) at 37 °C for 30 min. These samples,
concentrated by Methanal (Fisher Scientific) and Chloro-
form (Sigma-Aldrich), were detected by chemiluminescent
reagents (Bio-Rad) and then incubated with anti-OVA
(Sigma-Aldrich) and secondary antibody (Thermo Scien-
tific) for Western Blot analysis.
Mutu DCs (5 × 105) were pulsed with γFe2O3/APTS
and γFe2O3/DMSA (100 μg/ml) cocultured with OVA
(10 μg/ml) at 37 °C for different time points. Samples of
cell total lysates were incubated with the antibody of
anti-OVA and anti-LC3 proteins (Santa cruz) at 4 °C
overnight and secondary antibody (Thermo Scientific)
labeled with horseradish peroxidase for another one
hour in the following morning.
To determine the amount of OVA protein absorbed by
NPs, OVA protein (10 and 100 μg) was cocultured with
γFe2O3/APTS NPs or γFe2O3/DMSA NPs (100 μg) for
one hours at room temperature. A microplate BCA
assay kit (Pierce, Rockford, IL, USA) was used to meas-
ure the total protein content of OVA protein absorbed
by NPs according to manufacturer’s instructions. Bovine
serum albumin (BSA) provided in the kit was used as
the standard curve, and absorbance was read at 560 nm.
Statistical Analysis
Data were analyzed using the Statistical Package for
Social Science (version 13.0, SPSS Inc., Chicago, IL,
USA). Results were expressed as means ± standard devi-
ation. Differences between control and test groups were
assessed by one-way analysis of variance, two-tailed
Student’s t tests, and double factor analysis of variance.
The level of statistical significance was set at P < 0.05.
Results
Characterization of γFe2O3 NPs with Different Coatings
To determine the surface charges of NPs, we first mea-
sured the zeta potentials. The γFe2O3 NPs were coated
with DMSA or APTS and with or without OVA protein.
The pH values of the medias that were used to suspend
different γFe2O3 NPs were titrated to the levels from 3
to 8. Zeta potentials of γFe2O3/APTS NPs with or with-
out OVA protein showed positive charge characteristics,
which were not influenced by the pH values of the sus-
pension medium. On the contrary, γFe2O3/DMSA NPs
showed negative charge characteristics with the excep-
tion of point of zero charge when the pH value was 3
(Fig. 1). Therefore, our data infer that γFe2O3/APTS
NPs will stay positive charged when the pH is below 5,
but its charge will reduce as the pH value is higher than
5. On the contrary, the potentials of γFe2O3/DMSA NPs
keeps negative when the pH values were between 5 and
8 With pH values declining from 5 to 3, the potentials
gradually close in on the isoelectric point (IP).
γFe2O3 NPs Activated Murine DCs Cross-Presentation
To further investigate the effect of surface on the T-cell
activation in a murine system, γFe2O3/APTS and
γFe2O3/DMSA NPs were incubated with OVA protein at
different concentrations for 1 h at room temperature
and loaded into Mutu DCs for 6 h. Five dose ratios of
γFe2O3 NPs were adopted in this study, which were 3,
10, 30, 100, and 300 μg/ml. Then B3Z cells were cocul-
tured with Mutu DCs for another 12 h. The degree of
T-cell activation was determined by measuring the pro-
duction of beta-galactosidase with CPRG assay as the
colorimetric substrate. As shown in Fig. 2, we observed
that γFe2O3/APTS coated with 30–300 μg/ml OVA
protein yielded a sufficient response of antigen cross-
presentation and there were no significant differences
between these concentrations. On the contrary, γFe2O3/
DMSA NPs had no significant effect on the cross- presen-
tation. Meanwhile, the same doses of OVA protein alone
were also not cross-presented to T cells by Mutu DCs.
Cross-Presentation of OVA Protein Dependents on
Proteasome TAP1 Pathway
To investigate the mechanism of OVA protein cross-
presentation by DCs, murine BMDCs were generated
from TAP1 knockout mice and cocultured with γFe2O3/
Fig. 1 pH-dependent zeta potential curves of γFe2O3 NPs coated
with different charged molecules
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APTS and γFe2O3/DMSA coated with OVA protein
before they were used to stimulate B3Z T cells. The
CPRG results showed that T cells incubated with TAP1
knockout BMDCs had no significant response to B3Z
cells. (Fig. 3).
To further assess whether cross-presentation of OVA
protein with NPs requires proteasome or lysosome deg-
radation for presentation, we used velcade and NH4Cl,
which are highly specific inhibitors of the proteasome
and lysosome [18]. After incubated with γFe2O3 NPs
coated OVA protein and different inhibitors for 6 h,
DCs cross-presentation capacity was strongly inhibited
by velcade but not by NH4Cl (Fig. 4). These results
showed that cross-presentation mediated by γFe2O3 NPs
was proteasome and TAP1 dependent, but lysosome-
independent.
Location of NPs with Opposite Charges in DCs Under TEM
The ultrastructure of DCs labeled with γFe2O3 NPs with
opposite charged polymers and protein were observed
by using transmission electron microscopy (TEM). As
shown in Fig. 5, DCs treated with γFe2O3 NPs displayed
electron-dense NPs compared to untreated cells, which
displayed numerous γFe2O3 NPs huddled together in the
cytoplasm.
The γFe2O3 NPs with positive APTS were either swal-
lowed by endosomes or remained free in the cytoplasm
(Fig. 5b). On the contrary, more γFe2O3 NPs with the
negative polymer, DMSA, were observed in the cytoplasm
of DCs and almost all the particles were surrounded by
double or more layered membrane structures that resem-
bled autolysosomes could be seen. (Fig. 5c).
Induction of Autophagy by γFe2O3 NPs with Different
Charged Polymers
Previously, we have shown that NPs promote cross-
presentation and require APCs autophagy [9]. In order
to understand the reasons why the positive charged
γFe2O3 NPs could help DCs cross-presentation, we ana-
lyzed the autophagy protein LC3 by western blot. We
found that LC3-II formation was in a time-dependent
manner and it required approximate 3 h to reach max-
imum. The γFe2O3/DMSA with negative charges in-
duced the formation of LC3-II protein 1.5 h earlier than
the γFe2O3/APTS NPs (Fig. 6). These results indicate
that both negative and positive charged NPs could
induce autophagy, and negative charged NPs induced
autophagy more rapidly than positive charged NPs.
OVA Absorption by NPs and Cytosolic Delivery
To further understand why γFe2O3 NPs coated with
APTS could help DCs cross-presentation, we firstly ex-
amined the OVA protein absorption ability of NPs.
There was a considerable difference between the two
NPs and the similar result was detected between the two
doses of OVA protein. Due to the different surface
charges, the amount of OVA protein absorbed by
γFe2O3/APTS NPs and γFe2O3/DMSA NPs (100 μg)
were 4.87 and 7.98 μg in the 10 μg OVA group and 7.57
and 21.30 μg in the 100 μg OVA group, respectively
Fig. 2 γFe2O3 NPs with different charge molecules active Mutu
DCs cross-presentation
Fig. 3 Cross-presentation of OVA protein by DCs through
TAP1 passway
Fig. 4 Cross-presentation of OVA protein through proteasome in
Mutu DCs
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(Fig. 7). There were significant differences in the two
groups.
Negative charged γFe2O3 NPs can absorb more anti-
gen protein than positive charged γFe2O3 NPs, but they
were less efficiently cross-presented than positive
charged NPs. We postulate that cytosolic delivery of
OVA is influenced by surface charge variability. We
collected cytosol for Western Blot analysis from DCs
cocultured with OVA and opposite charged γFe2O3 NPs
for 30 min after PFO was added. There was an obvious
signal of OVA in the γFe2O3/APTS NPs group, which
means OVA protein was released from the cytosol. By
contrast, there was no signal in the γFe2O3/DMSA NPs
group. Without PFO treatment, DC loaded with NPs
coated with OVA did not release any proteins into
supernatants (Fig. 8).
Discussion
The synthetic SPIO NPs have been used as a cell label-
ing and imaging contrasting agent safely and effectively
in our previous studies [12, 13]. The crystalline core of
these particles is composed of γFe2O3 NPs and carry a
positive surface charge of 20.9 mV. These particles have
an average diameter of 8.7 nm and a hydrodynamic size
of 92 nm [19]. Two opposite charged coating, APTS
(positive) and DMSA (negative), were selected in this
study to investigate the influence of surface charge on
the antigen delivery and antigenic cross-presentation by
DCs. It has been shown by zeta potential measurement
that γFe2O3/DMSA particles have a high negative poten-
tial, while γFe2O3/APTS particles have a (low/high)
positive potential [15]. These different charges may be
attributed to the different functional groups, such as the
carboxyl and sulfylhydryl groups, which ionize in the
physiochemical state. Furthermore, these particles will
roll into the endocytosis transports process after they
enter into the cells. We still do not know the delivery
process after the charged particles are engulfed into the
cells. And, the influence in the delivery systems of the
APCs is not clear after the SPIO NPs coated with oppos-
ite charged polymers enters into the cells.
To answer these questions, the zeta potentials of dif-
ferent NPs coated with or without OVA were detected
in various pH values. According to the IP of OVA pro-
tein (pH = 4.8), which is an acidic protein under physio-
logical condition [20]. The potential will be positive
when the pH is under 4.8 and negative above 4.8.
We attempted to determine whether γFe2O3 NPs
coated with different charged coatings, APTS or DMSA,
could be used as adjuvants to promote antigen cross-
presentation by DCs. OVA protein was selected as
models antigens. Mutu DCs, an immortalized murine
DCs cell line, was used as APCs. Meanwhile murine B3Z
cell line was chosen as the responder cells and these
cells activation were detected by the assay of CPRG.
In our studies, we showed that OVA protein could be
presented by murine DCs to CD8 positive T cells
Fig. 5 a DCs, which were without γFe O NPs labeling, had round shape and the cytoplasm was uniform. The scale bar represents 1μm. DCs labeled
with γFe O /APTS (b) and γFe O /DMSA (c) were imaged by the magnification of 600 nm
Fig. 6 Autophagy in Mutu DCs pulsed with γFe2O3 NPs coated with
different polymers Fig. 7 OVA protein absorbed by NPs
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efficiently with the help of γFe2O3/APTS. On the con-
trary, even though the antigens could be brought into
DCs by γFe2O3/DMSA, they failed to induce an effective
T cell response (Fig. 2). These results suggest that the
vessel charges around the NPs play an important role in
the delivery of vaccines into APCs and also influence
antigen cross-presentation, which optimizes the surface
properties of NPs as being adjuvants. It has been re-
ported that the DMSA modification may facilitate SPIO
and gold nano-shells adhesion to the cells membrane
and enhance the cellular uptake [21, 22]. However, we
titrated the antigens and γFe2O3 NPs coated with APTS
or DMSA at different concentrations of DCs cross-
presentation and found that the response of T cells
induced by γFe2O3/DMSA delivery antigens was much
lower than that of γFe2O3/APTS when the concentra-
tions of γFe2O3 NPs were between 10 to 300 μg/ml.
Both kinds of particles express almost no T cell re-
sponses when the concentration of particles was below
3 μg/ml. Thus, we can draw the conclusion that positive
charged γFe2O3 NPs could function as efficient adjuvant
for antigen cross-presentation, but the γFe2O3 NPs with
negative charged coating cannot despite of more pro-
teins being brought into cells.
Based on previous reports, cytosolic antigens were
degraded into peptides by the proteasome and then
transported into the ER by the transporter TAP1 during
antigen cross-presentation. Peptides loaded with MHC-I
molecules were then released to the cell surface via the
Golgi. DCs have the capacity to present peptides
degraded from endogenous or exogenous antigens on
MHC I molecules through cross-presentation. CD8
positive T cells are activated by DCs through antigen
cross-presentation, an important mechanism for the de-
velopment of cytotoxic T cell (CTL) responses against
pathogens and tumors [23]. Among cross-presentation,
one of the most important routes is the cytosolic path-
way, in which the antigens are translocated from phago/
endosome into the cytosol, where they are further proc-
essed by the proteasome and TAP1 transporter but not
the lysosomal proteases [23].
To demonstrate whether the TAP1-transporters path-
way is related to the antigen transmission for cross-
presentation in the cytosol, the TAP1 knockout DCs was
induced in our study. Compared with Mutu DCs, we
found that there was almost no response after TAP1 was
knocked out from the DCs (Fig. 3). Collected data
showed the pathway of antigen delivery in DCs for
cross-presentation activated by the positive charged NPs
was TAP1 dependent. To further clarify the antigen de-
livery route in DCs, proteasome and lysosome inhibitors,
velcade and NH4Cl, were adopted in these studies. In
DC cross-presentation, NH4Cl did not block the T cells
responses. However, velcade blocked it completely
(Fig. 4). These data revealed that OVA protein can be
presented by DCs to CD8+ T cells via the proteasome
but not the lysosome. To further explain this question,
location of γFe2O3 NPs with opposite charged polymers
in DCs were examined by TEM. According to TEM,
γFe2O3 NPs with positive charged APTS stayed in the
early endosome or in the cytoplasm, while negative
charged γFe2O3/DMSA was be found in the lysosome or
autolysome covered by single or multi-layered mem-
brane vacuoles (Fig. 5).
Since autophagy plays an important role in antigen
cross-presentation in APCs, we studied the autophagic
proteins LC3-I and LC3-II by Western Blot. We found
that the expression of autophagic typical protein, LC3-II,
in DCs cocultured with a negative charged polymer was
much faster than that of positive charged polymer.
Within a 6-hour time frame, we found that both nega-
tive and positive charged NPs expressed nearly the same
amount of LC3-II. Therefore, we deduce that opposite
charged NPs induce different levels of antigen cross-
presentation and are not influenced by autophagy. It has
been established between autophagy and innate or adap-
tive immunity that autophagy can regulate the intracel-
lular killing of some bacteria and is also involved in the
presentation of antigens through MHC-I and MHC-II
molecules [24, 25]. From these results, we believe anti-
gen proteins with negative charged NPs are swallowed
into DCs, where they remain in the lysosome or autop-
hagosome to induce more autophagy and release more
cytokines (Fig. 6).
Fig. 8 OVA expression in the cytosol and total lysate of DC
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Even protein together with opposite charged NPs can be
delivered through the proteasome, inducing autophagy
and the inflammasome in DCs. In order to support our
hypothesis, it is needed to demonstrate that the protein
stayed in the DC’s cytosol. To prove this, OVA protein ex-
pression was examined in the cytosol of DCs by Western
Blot. We used the membrane pore forming protein, PFO,
which can perforate the cytomembrane and release the
cytosolic proteins into the medium. If the OVA proteins
cross the endosome membrane and translocated into the
cytosol, it will be released by PFO and detected by western
bolt. On the contrary, OVA protein will not be detected in
PFO treated cell supernatant if it is sequestered in the
lysosome, endosomes, or other compartments. We hy-
pothesized that positive charged NPs promote cross-
presentation by delivering more OVA into the cytosol. In
Fig. 8, OVA protein did release from the cytoplasm of
DCs cocultured with γFe2O3/APTS NPs after perforation
by PFO. However, OVA protein was not found in cytosol
of γFe2O3/DMSA NPs groups. Our collected data dis-
played that the antigen engulfed together with γFe2O3
NPs coated with positive charged polymer was located in
the cytosol of DCs where it participated in antigen cross-
presentation via the proteasome pathway. On the other
hand, the antigen combined with γFe2O3 NPs coated with
negative charged polymer did not exist in the cytosol
of DCs. These results infer that the antigen with
γFe2O3 NPs coated with the negative charged polymer
sequesters in the compartments of DCs. Based on
previous reports [15, 26], we speculated that γFe2O3
NPs coated with negative charged polymer will gather
in lysosome or autophagosome of the DCs.
In summary, current studies prove that antigen cross-
presentation of DCs can be enhanced by γFe2O3 NPs
modified by positive charged molecules. These antigens
were brought into DCs by γFe2O3/APTS and then cross-
presented to T cells through the cytosolic pathway,
which involved the proteasome and TAP1 transporter.
However, the negative charged NPs inhibited the DCs
functions by sequestering the antigen in the intracellular
compartments and activating rapid autophagy. Overall,
our results suggest that NPs modified with different
chemistry exhibit diverse biological properties and differ
in their adjuvant potentials. This will make us consider
more comprehensively and carefully design of effective
and safe adjuvants in the future.
Conclusions
The positive charged particles can promote the antigen
delivery in cytoplasm, which is beneficial for antigen
cross-presentation of DCs and T-cell activation. NPs
modified with different chemistries exhibit diverse bio-
logical properties and differ greatly in their adjuvant
potentials.
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